Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Saurabh Sethi

General GI · Oja Health

View

Dr. Wendi LeBrett

General GI · ModernGut

View

Dr. Treta Purohit

General GI · Oshi Health

View

Dr. Rushabh Modi

General GI · Kaiser Permanente

View

Dr. Brennan Spiegel

General GI · Cedars-Sinai

View

Dr. Mark Pochapin

General GI · NYU Langone

View

Dr. Amy Oxentenko

General GI · Mayo Clinic College of Medicine

View

Dr. Edward Sheen

General GI · L.A. Care

View

Dr. Sara Horst

IBD · Vanderbilt

View

Dr. Nneka Ufere

Liver Transplant · MGH

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    AM

    Dr. Antony Mathew

    Gastroenterology · General Gastroenterology
    Methodist Southlake Medical Center
    antony

    Research

    Differential Disease Behavior of Immune-Mediated Colitis Among Different Types of Immune Checkpoint Inhibition

    2025

    Via Targeted Oncology

    Research

    The Effect of PD-1/PD-L1 Inhibitor and Statin Combination Therapy on Overall Survival and Gastrointestinal Toxicity

    2024

    Via American Journal of Clinical Oncology

    Research

    Efficacy and safety of atezolizumab/bevacizumab in patients with HCC after prior systemic therapy: A global, observational study

    2023

    Via Hepatology Communications

    Research

    Role of C-Reactive Protein in Predicting the Severity and Response of Immune-Mediated Diarrhea and Colitis in Patients with Cancer

    2023

    Via Journal of Cancer

    Research

    Obesity Measured via Body Mass Index May Be Associated with Increased Incidence but Not Worse Outcomes of Immune-Mediated Diarrhea and Colitis

    2023

    Via Cancers

    Research

    Immune checkpoint inhibitor-related gastrointestinal toxicity in patients with malignancy involving the luminal gastrointestinal tract and its impact on cancer outcomes

    2022

    Via Annals of Gastroenterology

    Research

    Characteristics of appendicitis after immune checkpoint inhibitor therapy among cancer patients

    2022

    Via Journal of Cancer Research and Clinical Oncology

    Research

    Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity

    2022

    Via Cancer Cell